封面
市場調查報告書
商品編碼
1454122

IVD 心臟病學和神經病學市場,按產品類型、技術、最終用途、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

IVD In Cardiology And Neurology Market, By Product Type, By Technology, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 300 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年,心臟病學和神經病學 IVD 市場規模為 159.65 億美元,2024 年至 2032 年複合CAGR為 9.5%。

IVD 在心臟病學和神經病學市場的應用-市場動態

心血管疾病盛行率不斷上升推動市場需求

心血管疾病的日益流行預計將在預測期內推動心臟病學和神經病學市場的 IVD 發展。例如,根據美國國立衛生研究院公佈的資料,預計印度因心血管疾病死亡的人數將從1990年的226萬人增加到2020年的477萬人。印度的冠心病發病率各不相同,農村地區的冠心病發生率從1.6% 到7.4% 不等,大城市地區的冠心病發生率從1% 到13.2% 不等。因此,上述統計數據推動了市場成長。

心臟病學和神經病學市場中的體外診斷 (IVD) - 關鍵見解

根據我們的研究分析師分享的分析,預計全球市場在預測期內(2024-2032 年)每年將以 9.5% 左右的CAGR成長

根據產品類型細分,試劑和消耗品領域預計將在預測期內佔據重要的市場佔有率

根據技術細分,免疫分析領域在 2023 年佔據最大市場佔有率

根據最終用途細分,預計醫院細分市場將在預測期內引領市場

按地區分類,北美是 2023 年的主要收入來源

心臟病學和神經病學市場中的 IVD 細分分析:

全球心臟病學和神經病學 IVD 市場根據產品類型、技術、最終用途和地區進行細分。

根據產品類型,市場分為儀器、試劑和消耗品以及軟體和服務。試劑和消耗品部門預計將在預測期內佔據重要的市場佔有率。在免疫化學實驗中,使用的試劑包括螢光標籤、洗滌緩衝液、特定抗體和蛋白質生物標記。 PCR 測試使用多種物質進行,包括氯化鎂、dNTP 混合物和引子混合物。引子組和螢光標記的核苷酸是分子診斷過程中主要且最常用的試劑。雅培、羅氏診斷和 Illumina, Inc. 是試劑的主要供應商。該領域的崛起歸功於主要製造商透過大量研發活動開發創新生物標記試劑盒。此外,預計新型試劑的推出和商業化將推動市場擴張。

根據技術,市場分為分子診斷、免疫分析、血液學和其他。免疫測定在 2023 年佔據最大的市場佔有率,預計在預測期內將繼續保持相同的模式。在免疫學中研究分子途徑,以了解免疫系統所扮演的不同角色。它主要包括評估抗原和抗體之間的相互作用及其作用機制。企業正專注於免疫測定的創建和行銷。

根據最終用途,該行業分為臨床實驗室、醫院和其他。由於醫生需要診斷解釋才能進行治療,醫院細分市場預計將在預計期間引領市場,預計該細分市場將會發展。

心臟病學和神經病學市場中的 IVD - 地理洞察

從地理來看,該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。由於心血管和神經系統疾病盛行率的不斷上升以及有益的政府計劃的擴大等多種變數,預計北美在預測期內將引領心臟病學和神經病學 IVD 市場。預計更多產品的發布和創新生物標誌研發融資也將推動市場的成長。

心臟病學和神經病學市場中的 IVD-競爭格局:

市場上的主要參與者包括 Quest Diagnostics Incorporated、BD、Sysmex Corporation、Siemens Healthineers AG、Thermo Fisher Scientific Inc.、Abbott、F. Hoffmann-La Roche Ltd.、Bio-Rad Laboratories, Inc.、Beckman Coulter, Inc. .和心臟治療。為了進入新市場,市場參與者不斷採取各種策略性舉措,包括創造新產品、融資和投資、併購以及其他策略夥伴關係。

最近的發展:

2023 年 7 月,Fujirebio 和 Beckman Coulter, Inc. 之間的合作旨在改善患者獲得基於血液的阿茲海默症檢測的機會。此次合作旨在匯集該公司的免疫分析能力來提供支援。

目錄

第 1 章:心臟病學和神經病學領域的 IVD 市場概述

  • 研究範圍
  • 市場預估年份

第 2 章:執行摘要

  • 市場片段
    • 心臟病學和神經病學領域的 IVD 市場片段(按產品類型)
    • 心臟病學和神經病學領域的 IVD 市場片段(按技術)
    • 心臟病學和神經病學領域的 IVD 市場片段(按最終用途)
    • 心臟病學和神經病學領域的 IVD 市場片段(按國家/地區)
    • 心臟病學和神經病學領域的 IVD 市場片段(按地區)
  • 競爭洞察

第 3 章:心臟病學和神經病學領域的 IVD 主要市場趨勢

  • 心臟病學和神經病學領域的 IVD 市場促進因素
    • 市場促進因素的影響分析
  • 心臟病學和神經病學領域的 IVD 市場限制
    • 市場限制影響分析
  • 心臟病學和神經病學領域的 IVD 市場機會
  • 心臟病學和神經病學領域的 IVD 市場未來趨勢

第 4 章:心臟病學和神經病學領域的 IVD 產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章:心臟病學和神經病學市場中的 IVD:COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章:心臟病學和神經病學領域的 IVD 市場格局

  • 心臟病學和神經病學 IVD 市場佔有率分析,2023 年
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章:心臟病學和神經病學市場中的 IVD - 按產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 儀器
    • 試劑及耗材
    • 軟體和服務

第 8 章:心臟病學和神經病學市場中的 IVD - 按技術

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 分子診斷
    • 免疫測定
    • 血液學
    • 其他

第 9 章:心臟病學和神經病學市場中的 IVD - 按最終用途

  • 概述
    • 按最終用途分類的細分市場佔有率分析
    • 臨床實驗室
    • 醫院
    • 其他

第 10 章:心臟病學和神經病學領域的 IVD 市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 心臟病學和神經學領域的 IVD 北美主要製造商
    • 北美市場規模和預測(按國家)
    • 北美市場規模和預測(按產品類型)
    • 北美市場規模和預測(按技術)
    • 北美市場規模和預測(按最終用途)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 心臟病學和神經學領域的體外診斷 (IVD) 歐洲主要製造商
    • 歐洲市場規模和預測(按國家)
    • 歐洲市場規模和預測(按產品類型)
    • 歐洲市場規模與預測(按技術)
    • 歐洲市場規模和預測(按最終用途)
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 心臟病學和神經病學領域的體外診斷 (IVD) 亞太地區主要製造商
    • 亞太地區市場規模與預測(按國家)
    • 亞太地區市場規模與預測(依產品類型)
    • 亞太地區市場規模與預測(按技術)
    • 亞太地區市場規模和預測(按最終用途)
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 心臟病學和神經學領域的體外診斷 (IVD) 拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測(按國家)
    • 拉丁美洲市場規模與預測(按產品類型)
    • 拉丁美洲市場規模與預測(按技術)
    • 拉丁美洲市場規模和預測(按最終用途)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 心臟病學和神經學領域的 IVD 中東和非洲主要製造商
    • 中東和非洲市場規模及預測(按國家)
    • 中東和非洲市場規模及預測(按產品類型)
    • 中東和非洲市場規模及預測(按技術)
    • 中東和非洲市場規模和預測(按最終用途)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章:主要供應商分析 - 心臟病學和神經病學行業的 IVD

  • 競爭儀表板
  • 公司簡介
    • Quest Diagnostics Incorporated
    • BD
    • Sysmex Corporation
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • Bio-Rad Laboratories, Inc.
    • Beckman Coulter, Inc.
    • Cardiol Therapeutics

第 12 章:360 度分析師視角

第 13 章:附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2303

REPORT HIGHLIGHT

IVD In Cardiology And Neurology Market size was valued at USD 15,965 Million in 2023, expanding at a CAGR of 9.5% from 2024 to 2032.

The term "in vitro diagnostics" (IVD) describes the use of instruments, techniques, and reagents designed for the analysis of specimens-such as blood, urine, tissue, and other bodily fluids-outside of the body to aid in the diagnosis of illnesses, ailments, or infections. These laboratory-based tests are intended to give information on a patient's health state, supporting the identification of illnesses, selection of appropriate courses of treatment, and ongoing monitoring of those illnesses.

IVD In Cardiology And Neurology Market- Market Dynamics

Growing prevalence of cardiovascular disease to propel market demand

The growing prevalence of cardiovascular disease is expected to propel the IVD In Cardiology And Neurology market over the projected period. For instance, according to the data published by National Institutes of Health, it is anticipated that the number of fatalities in India from CVD would increase from 2.26 million in 1990 to 4.77 million in 2020. Over the past few decades, estimates of the prevalence of coronary heart disease in India have varied, with figures ranging from 1.6% to 7.4% in rural areas and from 1% to 13.2% in metropolitan areas. Thus, the aforementioned stats drive the market growth.

IVD In Cardiology And Neurology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.5% over the forecast period (2024-2032)

Based on product type segmentation, the Reagents & Consumables segment is expected to capture a significant market share during the forecast period

Based on the technology segmentation, the Immunoassays segment held the largest market share in 2023

Based on end-use segmentation, the hospitals segment is expected to lead the market over the projected period

Based on region, North America was the leading revenue generator in 2023

IVD In Cardiology And Neurology Market- Segmentation Analysis:

The Global IVD In Cardiology And Neurology Market is segmented based on Product Type, Technology, End-use, and Region.

Based on the product type, the market is categorized into Instruments, Reagents & Consumables and Software and Services. The Reagents & Consumables segment is expected to capture a significant market share during the forecast period. In immunochemistry experiments, reagents including fluorescent tags, washing buffers, particular antibodies, and protein biomarkers are utilized. PCR tests are carried out using a variety of substances, including magnesium chloride, dNTP mix, and primer mix. Primer sets and fluorescent-labeled nucleotides are the main and most commonly utilized reagents in molecular diagnostic procedures. Abbott, Roche Diagnostics, and Illumina, Inc. are the main suppliers of reagents. The development of innovative biomarker kits by key manufacturers through considerable R&D activities is credited with the segment's rise. Additionally, it is anticipated that the launch and commercialization of novel reagents would propel market expansion.

Based on the technology, the market is divided into Molecular Diagnostics, Immunoassays, Hematology and Others. The Immunoassays held the largest market share in 2023 and is expected to continue the same pattern during the forecast period. Molecular pathways are studied in immunology to comprehend the diverse roles that the immune system plays. It primarily consists of an evaluation of the interactions between antigens and antibodies as well as their mechanisms of action. Businesses are concentrating on the creation and marketing of immunoassays.

Based on the end-use, the industry is divided into Clinical Laboratories, Hospitals and Others. The hospitals segment is expected to lead the market over the projected period due to the fact that physicians need diagnostic interpretation to proceed with therapy, the segment is expected to develop.

IVD In Cardiology And Neurology Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to lead the IVD In Cardiology And Neurology market during the forecast period due to a number of variables, including the growing prevalence of cardiovascular and neurological diseases and the expansion of beneficial government programs. Growth in the market is also anticipated to be fueled by more product releases and financing for the R&D of innovative biomarkers.

IVD In Cardiology And Neurology Market- Competitive Landscape:

The key players operating in the market are Quest Diagnostics Incorporated, BD, Sysmex Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Abbott, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc. and Cardiol Therapeutics. To obtain access to new markets, market players are continuously pursuing a variety of strategic initiatives, including the creation of new products, funding and investments, mergers and acquisitions, and other strategic partnerships.

Recent Developments:

In July 2023, a collaboration between Fujirebio and Beckman Coulter, Inc. aims to improve patient access to blood-based Alzheimer disease testing. The collaboration intends to pool the business's immunoassay capabilities to provide support.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Quest Diagnostics Incorporated

BD

Sysmex Corporation

Siemens Healthineers AG

Thermo Fisher Scientific Inc.

Abbott

F. Hoffmann-La Roche Ltd.

Bio-Rad Laboratories, Inc.

Beckman Coulter, Inc.

Cardiol Therapeutics

GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Instruments
  • Reagents & Consumables
  • Software and Services

GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Molecular Diagnostics
  • Immunoassays
  • Hematology
  • Others

GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Clinical Laboratories
  • Hospitals
  • Others

GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.IVD IN CARDIOLOGY AND NEUROLOGY Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.IVD IN CARDIOLOGY AND NEUROLOGY Market Snippet by Product Type
    • 2.1.2.IVD IN CARDIOLOGY AND NEUROLOGY Market Snippet by Technology
    • 2.1.3.IVD IN CARDIOLOGY AND NEUROLOGY Market Snippet by End-use
    • 2.1.4.IVD IN CARDIOLOGY AND NEUROLOGY Market Snippet by Country
    • 2.1.5.IVD IN CARDIOLOGY AND NEUROLOGY Market Snippet by Region
  • 2.2.Competitive Insights

3.IVD IN CARDIOLOGY AND NEUROLOGY Key Market Trends

  • 3.1.IVD IN CARDIOLOGY AND NEUROLOGY Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.IVD IN CARDIOLOGY AND NEUROLOGY Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.IVD IN CARDIOLOGY AND NEUROLOGY Market Opportunities
  • 3.4.IVD IN CARDIOLOGY AND NEUROLOGY Market Future Trends

4.IVD IN CARDIOLOGY AND NEUROLOGY Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.IVD IN CARDIOLOGY AND NEUROLOGY Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.IVD IN CARDIOLOGY AND NEUROLOGY Market Landscape

  • 6.1.IVD IN CARDIOLOGY AND NEUROLOGY Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.IVD IN CARDIOLOGY AND NEUROLOGY Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Instruments
    • 7.1.3.Reagents & Consumables
    • 7.1.4.Software and Services

8.IVD IN CARDIOLOGY AND NEUROLOGY Market - By Technology

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 8.1.2.Molecular Diagnostics
    • 8.1.3.Immunoassays
    • 8.1.4.Hematology
    • 8.1.5.Others

9.IVD IN CARDIOLOGY AND NEUROLOGY Market - By End-use

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-use, 2023 & 2032 (%)
    • 9.1.2.Clinical Laboratories
    • 9.1.3.Hospitals
    • 9.1.4.Others

10.IVD IN CARDIOLOGY AND NEUROLOGY Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.IVD IN CARDIOLOGY AND NEUROLOGY Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.IVD IN CARDIOLOGY AND NEUROLOGY Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.IVD IN CARDIOLOGY AND NEUROLOGY Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.IVD IN CARDIOLOGY AND NEUROLOGY Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.IVD IN CARDIOLOGY AND NEUROLOGY Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- IVD IN CARDIOLOGY AND NEUROLOGY Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Quest Diagnostics Incorporated
    • 11.2.2.BD
    • 11.2.3.Sysmex Corporation
    • 11.2.4.Siemens Healthineers AG
    • 11.2.5.Thermo Fisher Scientific Inc.
    • 11.2.6.Abbott
    • 11.2.7.F. Hoffmann-La Roche Ltd.
    • 11.2.8.Bio-Rad Laboratories, Inc.
    • 11.2.9.Beckman Coulter, Inc.
    • 11.2.10.Cardiol Therapeutics

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE IVD IN CARDIOLOGY AND NEUROLOGY Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global IVD IN CARDIOLOGY AND NEUROLOGY Market, by Product Type 2019-2032 (USD Million)
  • TABLE IVD IN CARDIOLOGY AND NEUROLOGY Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global IVD IN CARDIOLOGY AND NEUROLOGY Market, by Technology 2019-2032 (USD Million)
  • TABLE IVD IN CARDIOLOGY AND NEUROLOGY Market: End-useSnapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-use
  • TABLE Global IVD IN CARDIOLOGY AND NEUROLOGY Market, by End-use2019-2032 (USD Million)
  • TABLE IVD IN CARDIOLOGY AND NEUROLOGY Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global IVD IN CARDIOLOGY AND NEUROLOGY Market, by Region 2019-2032 (USD Million)
  • TABLE North America IVD IN CARDIOLOGY AND NEUROLOGY Market, by Country, 2019-2032 (USD Million)
  • TABLE North America IVD IN CARDIOLOGY AND NEUROLOGY Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America IVD IN CARDIOLOGY AND NEUROLOGY Market, by Technology, 2019-2032 (USD Million)
  • TABLE North America IVD IN CARDIOLOGY AND NEUROLOGY Market, by End-use, 2019-2032 (USD Million)
  • TABLE Europe IVD IN CARDIOLOGY AND NEUROLOGY Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe IVD IN CARDIOLOGY AND NEUROLOGY Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe IVD IN CARDIOLOGY AND NEUROLOGY Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe IVD IN CARDIOLOGY AND NEUROLOGY Market, by End-use, 2019-2032 (USD Million)
  • TABLE Asia Pacific IVD IN CARDIOLOGY AND NEUROLOGY Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific IVD IN CARDIOLOGY AND NEUROLOGY Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific IVD IN CARDIOLOGY AND NEUROLOGY Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific IVD IN CARDIOLOGY AND NEUROLOGY Market, by End-use, 2019-2032 (USD Million)
  • TABLE Latin America IVD IN CARDIOLOGY AND NEUROLOGY Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America IVD IN CARDIOLOGY AND NEUROLOGY Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America IVD IN CARDIOLOGY AND NEUROLOGY Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America IVD IN CARDIOLOGY AND NEUROLOGY Market, by End-use, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IVD IN CARDIOLOGY AND NEUROLOGY Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IVD IN CARDIOLOGY AND NEUROLOGY Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IVD IN CARDIOLOGY AND NEUROLOGY Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IVD IN CARDIOLOGY AND NEUROLOGY Market, by End-use, 2019-2032 (USD Million)

List of Figures

  • FIGURE IVD IN CARDIOLOGY AND NEUROLOGY Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product Type segment market share analysis, 2023 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Technology segment market share analysis, 2023 & 2032
  • FIGURE Technology segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End-usesegment market share analysis, 2023 & 2032
  • FIGURE End-usesegment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America IVD IN CARDIOLOGY AND NEUROLOGY Market share and leading players, 2023
  • FIGURE Europe IVD IN CARDIOLOGY AND NEUROLOGY Market share and leading players, 2023
  • FIGURE Asia Pacific IVD IN CARDIOLOGY AND NEUROLOGY Market share and leading players, 2023
  • FIGURE Latin America IVD IN CARDIOLOGY AND NEUROLOGY Market share and leading players, 2023
  • FIGURE Middle East and Africa IVD IN CARDIOLOGY AND NEUROLOGY Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe IVD IN CARDIOLOGY AND NEUROLOGY Market share analysis by country, 2023
  • FIGURE Germany IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific IVD IN CARDIOLOGY AND NEUROLOGY Market share analysis by country, 2023
  • FIGURE India IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America IVD IN CARDIOLOGY AND NEUROLOGY Market share analysis by country, 2023
  • FIGURE Brazil IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa IVD IN CARDIOLOGY AND NEUROLOGY Market share analysis by country, 2023
  • FIGURE Saudi Arabia IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)